Latest

Obesity drug maker Novo Nordisk posts strong profit
Obesity drug maker Novo Nordisk posts strong profit
Economy
by  AFP

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by production constraints. Novo Nordisk has a hold on 74 percent of the market for weight-loss treatments.